First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study

1. Hideo-Kajita, A.
2. Garcia-Garcia, H.M.
3. Haude, M.
4. Joner, M.
5. Koolen, J.
6. Ince, H.
7. Abizaid, A.
8. Toelg, R.
9. Lemos, P.A.
10. von Birgelen, C.
11. Christiansen, E.H.
12. Wijns, W.
13. Neumann, F.-J.
14. Kaiser, C.
15. Eeckhout, E.
16. Teik, L.S.
17. Escaned, J.
18. Azizi, V.
19. Kuku, K.O.
20. Ozaki, Y.
21. Dan, K.
22. Waksman, R.